Lauren E. Damon

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

Catherine C. Smith, Qi Wang, Chen-Shan Chin et al. · Nature · 2012 · 734 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Crenolanib is a selective type I pan-FLT3 inhibitor

Catherine C. Smith, Elisabeth A. Lasater, Kimberly C. Lin et al. · Proceedings of the National Academy of Sciences · 2014 · 207 citations · Full text

Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397

Catherine C. Smith, Chao Zhang, Kimberly C. Lin et al. · Cancer Discovery · 2015 · 197 citations · Full text

Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD

Catherine C. Smith, Elisabeth A. Lasater, Xiaotian Zhu et al. · Blood · 2013 · 127 citations · Full text

Increased CD62e+ Endothelial Microparticle Levels Predict Poor Outcome in Pulmonary Hypertension Patients

Nicolas Amabile, Vivian Y. Chang, Franca S. Angeli et al. · The Journal of Heart and Lung Transplantation · 2009 · 109 citations

Endothelial Cell Pathobiology, Hypertension, Pulmonary Arterial Hypertension +13